Siponimod
Specifications
1230487-00-9CAS Number
1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acidIUPAC Name
C29H35F3N2O3Chemical Formula
516.6 g/molMolecular Weight
Siponimod; 1230487-00-9; BAF312; BAF-312; NVP-BAF312-NX; RR6P8L282I; 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid; BAF 312; DTXSID40153847; 1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid; 3-Azetidinecarboxylic acid, 1-((4-((1E)-1-(((4-cyclohexyl-3-(trifluoromethyl)phenyl)methoxy)imino)ethyl)-2-ethylphenyl)methyl)-; 3-Azetidinecarboxylic acid, 1-[[4-[(1E)-1-[[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethylphenyl]methyl]-; 1-({4-[(1E)-1-({[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy}imino)ethyl]-2-ethylphenyl}methyl)azetidine-3-carboxylic acid; siponimodum; 1-((4-((1E)-1-(((4-Cyclohexyl-3-(trifluoromethyl)phenyl)methoxy)imino)ethyl)-2-ethylphenyl)methyl)azetidine-3-carboxylic Acid; 1-((4-((E)-N-((4-cyclohexyl-3-(trifluoromethyl)phenyl)methoxy)-C-methylcarbonimidoyl)-2-ethylphenyl)methyl)azetidine-3-carboxylic acid; RefChem:57741; DTXCID0076338; L04AA42; Mayzent; BAF-312(SiponiMod); Siponimod [INN]; Siponimod [WHO-DD]; Siponimod [USAN]; 1230487-85-0; MFCD26142651; (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid; CHEMBL2336071; BAF312 (Siponimod); Siponimod (BAF312); 1-(4-[1-[(E)-4-Cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl]-2-ethyl-benzyl)-azetidine-3-carboxylic acid; C29H35F3N2O3; (E)-1-(4-(1-(4-cyclohexyl-3-(trifluoromethyl)benzyloxyimino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid; UNII-RR6P8L282I; 1-[[4-[(1E)-1-[[[4-Cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethylphenyl]methyl]-3-azetidinecarboxylic Acid; 1-(4-[1-[(E)-4-Cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl]-2-ethyl-benzyl)-azetidine-3-carboxylic Acid; BAF 312;; J8C; Siponimod (Standard); SIPONIMOD [MI]; Siponimod (USAN/INN); BAF312 (Siponimod)?; SCHEMBL641699; GTPL9289; orb1226725; orb1300798; SCHEMBL29362334; EX-A873; Siponimod [USAN:INN:WHO-DD]; GLXC-05932; HMS5085P12; 1-[[4-[(~{E})-~{N}-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-~{C}-methyl-carbonimidoyl]-2-ethyl-phenyl]methyl]azetidine-3-carboxylic acid; WHO 9491; BDBM50428142; EBC-27261; HY-12355R; AKOS027254138; AKOS037645089; CCG-269825; CS-3876; DB12371; compound 32 [PMID: 24900670]; NCGC00347938-03; 1-((4-((1E)-1-(((4-Cyclohexyl- 3-(trifluoromethyl)phenyl)methoxy)imino)ethyl)- 2-ethylphenyl)methyl)azetidine-3-carboxylic acid; AC-32779; AS-56983; DA-57888; FS103613; HY-12355; NS00070338; S7179; T6403; D11460; EN300-25360071; F799830; BRD-K62384160-001-01-2; BRD-K62384160-001-02-0; Q25100876; Z2568751224; N-[[4-Cyclohexyl-3 (trifluoromethyl) phenyl]methoxy]ethanimidic acidethyl ester; 1-({4-[(1E)-N-{[4-Cyclohexyl-3-(trifluoromethyl)phenyl]methoxy}ethanimidoyl]-2-ethylphenyl}methyl)azetidine-3-carboxylic acid; 1-[[4-[(1E)-1-[[[4-Cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethylphenyl]methyl]-3-azetidinecarboxylic acid; 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methyl-carbonimidoyl]-2-ethyl-phenyl]methyl]azetidine-3-carboxylic acid; 2(1H)-Isoquinolinebutanoic acid, beta-(((4,5-dihydro-5-(2-(1H-imidazol-2-ylamino)ethyl)-3-isoxazolyl)carbonyl)amino)-3,4-dihydro-gamma-oxo-Synonyms
